Cigna Corp (CI)vsClover Health Investments Corp (CLOV)
CI
Cigna Corp
$270.36
+1.69%
HEALTHCARE · Cap: $71.02B
CLOV
Clover Health Investments Corp
$1.82
0.00%
HEALTHCARE · Cap: $954.89M
Smart Verdict
WallStSmart Research — data-driven comparison
Cigna Corp generates 14192% more annual revenue ($274.90B vs $1.92B). CI leads profitability with a 2.2% profit margin vs -4.5%. CI earns a higher WallStSmart Score of 63/100 (C+).
CI
Buy63
out of 100
Grade: C+
CLOV
Hold36
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-79.3%
Fair Value
$150.76
Current Price
$270.36
$119.60 premium
Intrinsic value data unavailable for CLOV.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Generating 5.8B in free cash flow
Revenue surging 44.7% year-over-year
Areas to Watch
2.2% margin — thin
Operating margin of 3.5%
Weak financial health signals
Earnings declined 9.3%
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -26.3% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CI
The strongest argument for CI centers on P/E Ratio, Market Cap, PEG Ratio. Revenue growth of 10.4% demonstrates continued momentum. PEG of 0.76 suggests the stock is reasonably priced for its growth.
Bull Case : CLOV
The strongest argument for CLOV centers on Revenue Growth. Revenue growth of 44.7% demonstrates continued momentum.
Bear Case : CI
The primary concerns for CI are Profit Margin, Operating Margin, Piotroski F-Score. Thin 2.2% margins leave little buffer for downturns.
Bear Case : CLOV
The primary concerns for CLOV are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
CI profiles as a value stock while CLOV is a hypergrowth play — different risk/reward profiles.
CLOV carries more volatility with a beta of 2.24 — expect wider price swings.
CLOV is growing revenue faster at 44.7% — sustainability is the question.
CI generates stronger free cash flow (5.8B), providing more financial flexibility.
Bottom Line
CI scores higher overall (63/100 vs 36/100) and 10.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cigna Corp
HEALTHCARE · HEALTHCARE PLANS · USA
Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).
Visit Website →Clover Health Investments Corp
HEALTHCARE · HEALTHCARE PLANS · USA
Clover Health Investments, Corp. The company is headquartered in Franklin, Tennessee.
Visit Website →Compare with Other HEALTHCARE PLANS Stocks
Want to dig deeper into these stocks?